William J Burlingham Selected Research

William J Burlingham Research Topics

Disease

14	Hypersensitivity (Allergy) 06/2023 - 10/2002
6	Neoplasms (Cancer) 02/2020 - 11/2008
4	Bronchiolitis Obliterans Syndrome 01/2018 - 08/2010
4	Bronchiolitis 10/2010 - 11/2007
3	Coronary Artery Disease (Coronary Atherosclerosis) 02/2016 - 10/2010
3	Lymphoma (Lymphomas) 01/2015 - 01/2011
2	Inflammation (Inflammations) 12/2020 - 12/2009
2	Reperfusion Injury 12/2020 - 01/2018
2	Infections 02/2020 - 03/2005
2	Hyperplasia 11/2019 - 12/2015
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 11/2010
2	Atherosclerotic Plaque (Atheroma) 02/2016 - 10/2010
2	Atherosclerosis 02/2016 - 10/2010
2	Fibrosis (Cirrhosis) 12/2015 - 09/2013
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2014 - 05/2005
2	Idiopathic Pulmonary Fibrosis 01/2013 - 08/2010
2	Epstein-Barr Virus Infections 08/2012 - 01/2011
2	Vasculitis (Vasculitides) 12/2009 - 03/2008
2	Primary Graft Dysfunction 10/2008 - 03/2008
1	Pulmonary Hypertension 12/2020
1	Hypertension (High Blood Pressure) 12/2020
1	Hypoxia (Hypoxemia) 01/2019
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2016
1	Arteriosclerosis 12/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015
1	Alopecia (Baldness) 09/2013
1	Necrosis 05/2013
1	Edema (Dropsy) 05/2013
1	Prostatic Neoplasms (Prostate Cancer) 12/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2010
1	Disease Progression 10/2010
1	Gastroesophageal Reflux (GERD) 08/2010
1	Virus Diseases (Viral Diseases) 11/2008
1	Residual Neoplasm 11/2008
1	Human Influenza (Influenza) 05/2008
1	Lung Diseases (Lung Disease) 03/2008
1	Tetanus 11/2007
1	Hepatitis B 09/2007
1	Leukemia 05/2005

Drug/Important Bio-Agent (IBA)

8	Collagen Type V (Type V Collagen)IBA 12/2020 - 11/2007
7	AntigensIBA 07/2015 - 10/2002
3	AutoantigensIBA 12/2020 - 10/2010
3	InterleukinsIBA 02/2016 - 12/2009
2	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 06/2023 - 10/2002
2	CollagenIBA 12/2020 - 02/2016
2	Apolipoproteins E (ApoE)IBA 02/2016 - 10/2010
2	Interleukin-10 (Interleukin 10)IBA 01/2016 - 11/2007
2	Oncogene Proteins (Oncogene Protein)IBA 01/2015 - 08/2012
2	Viral ProteinsIBA 08/2012 - 01/2011
2	Isoantigens (Alloantigen)IBA 10/2010 - 05/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2009 - 03/2008
2	Prostaglandins DIBA 10/2008 - 03/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 11/2007 - 05/2004
1	TetraspaninsIBA 06/2023
1	ImmunosorbentsIBA 06/2023
1	EnzymesIBA 06/2023
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	transcription factor NF-AT c3IBA 12/2020
1	Calcineurin InhibitorsIBA 02/2020
1	RepSoxIBA 11/2019
1	Becaplermin (PDGF-BB)FDA Link 11/2019
1	Blood Substitutes (Artificial Blood)IBA 11/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	LigandsIBA 01/2018
1	CytokinesIBA 01/2016
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 12/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2015
1	Peptides (Polypeptides)IBA 01/2014
1	A-Form DNA (A-DNA)IBA 12/2012
1	VaccinesIBA 12/2012
1	prostatic acid phosphataseIBA 12/2012
1	Muromonab-CD3 (Muromonab CD3)FDA Link 08/2012
1	lacto-N-fucopentaose IIIIBA 11/2010
1	ApolipoproteinsIBA 10/2010
1	Interleukin-17 (Interleukin 17)IBA 12/2009
1	Interferon-gamma (Interferon, gamma)IBA 12/2009
1	MonokinesIBA 03/2008
1	Minor Histocompatibility AntigensIBA 05/2005
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2005
1	Metalloproteases (Metalloproteinases)IBA 03/2005
1	InterferonsIBA 03/2005
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2004

Therapy/Procedure

5	Lung Transplantation 01/2013 - 09/2007
3	Transplantation 01/2017 - 08/2009
3	Immunotherapy 12/2012 - 11/2008
1	Mucosal Administration 02/2016
1	Hematopoietic Stem Cell Transplantation 01/2014
1	Organ Transplantation 10/2013
1	Heart Transplantation (Grafting, Heart) 01/2013
1	Stem Cell Transplantation 05/2005
1	Liver Transplantation 10/2002